S06477 Summary:
BILL NO | S06477B |
  | |
SAME AS | SAME AS A08637-B |
  | |
SPONSOR | HANNON |
  | |
COSPNSR | BOYLE, BALL, CARLUCCI, DILAN, ESPAILLAT, GALLIVAN, GIPSON, GOLDEN, GRISANTI, HASSELL-THOMPSON, HOYLMAN, KENNEDY, KRUEGER, LANZA, LARKIN, LATIMER, LITTLE, MARCHIONE, MARTINS, MAZIARZ, MONTGOMERY, PARKER, RIVERA, SAVINO, SEWARD, SQUADRON |
  | |
MLTSPNSR | |
  | |
Amd S3309, Pub Health L | |
  | |
Provides for the use of opioid antagonists. |
S06477 Actions:
BILL NO | S06477B | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
01/28/2014 | REFERRED TO HEALTH | |||||||||||||||||||||||||||||||||||||||||||||||||
02/04/2014 | 1ST REPORT CAL.104 | |||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2014 | 2ND REPORT CAL. | |||||||||||||||||||||||||||||||||||||||||||||||||
02/11/2014 | ADVANCED TO THIRD READING | |||||||||||||||||||||||||||||||||||||||||||||||||
03/10/2014 | AMENDED ON THIRD READING (T) 6477A | |||||||||||||||||||||||||||||||||||||||||||||||||
03/18/2014 | AMENDED ON THIRD READING 6477B | |||||||||||||||||||||||||||||||||||||||||||||||||
03/27/2014 | PASSED SENATE | |||||||||||||||||||||||||||||||||||||||||||||||||
03/27/2014 | DELIVERED TO ASSEMBLY | |||||||||||||||||||||||||||||||||||||||||||||||||
03/27/2014 | referred to health | |||||||||||||||||||||||||||||||||||||||||||||||||
05/06/2014 | substituted for a8637b | |||||||||||||||||||||||||||||||||||||||||||||||||
05/06/2014 | ordered to third reading cal.618 | |||||||||||||||||||||||||||||||||||||||||||||||||
05/06/2014 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
05/06/2014 | returned to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
06/23/2014 | DELIVERED TO GOVERNOR | |||||||||||||||||||||||||||||||||||||||||||||||||
06/24/2014 | SIGNED CHAP.42 |
S06477 Floor Votes:
Yes
Abbate
Yes
Curran
Yes
Hawley
Yes
Markey
Yes
Quart
Yes
Steck
Yes
Abinanti
Yes
Cusick
Yes
Heastie
Yes
Mayer
Yes
Ra
Yes
Stirpe
Yes
Arroyo
Yes
Cymbrowitz
Yes
Hennessey
Yes
McDonald
Yes
Raia
Yes
Sweeney
Yes
Aubry
Yes
Davila
Yes
Hevesi
Yes
McDonough
Yes
Ramos
Yes
Tedisco
Yes
Barclay
Yes
DenDekker
Yes
Hikind
Yes
McKevitt
Yes
Rivera
Yes
Tenney
Yes
Barrett
Yes
Dinowitz
Yes
Hooper
Yes
McLaughlin
Yes
Roberts
Yes
Thiele
Yes
Benedetto
Yes
DiPietro
Yes
Jacobs
Yes
Miller
Yes
Robinson
Yes
Titone
Yes
Blankenbush
Yes
Duprey
Yes
Jaffee
Yes
Millman
Yes
Rodriguez
Yes
Titus
Yes
Borelli
Yes
Englebright
Yes
Johns
Yes
Montesano
Yes
Rosa
Yes
Walter
Yes
Braunstein
Yes
Fahy
ER
Katz
Yes
Morelle
Yes
Rosenthal
Yes
Weinstein
Yes
Brennan
Yes
Farrell
Yes
Kavanagh
Yes
Mosley
Yes
Rozic
ER
Weisenberg
Yes
Brindisi
Yes
Finch
Yes
Kearns
Yes
Moya
Yes
Russell
Yes
Weprin
Yes
Bronson
Yes
Fitzpatrick
Yes
Kellner
Yes
Nojay
Yes
Ryan
Yes
Wright
Yes
Brook-Krasny
Yes
Friend
Yes
Kim
ER
Nolan
Yes
Saladino
Yes
Zebrowski
Yes
Buchwald
Yes
Galef
Yes
Kolb
Yes
Oaks
Yes
Santabarbara
Yes
Mr. Speaker
Yes
Butler
Yes
Gantt
Yes
Lalor
Yes
O'Donnell
Yes
Scarborough
Yes
Cahill
Yes
Garbarino
Yes
Lavine
Yes
Ortiz
Yes
Schimel
Yes
Camara
Yes
Giglio
Yes
Lentol
Yes
Otis
Yes
Schimminger
Yes
Ceretto
ER
Gjonaj
Yes
Lifton
Yes
Palmesano
Yes
Sepulveda
Yes
Clark
Yes
Glick
Yes
Lopez
Yes
Palumbo
Yes
Simanowitz
Yes
Colton
Yes
Goldfeder
Yes
Lupardo
Yes
Paulin
Yes
Simotas
Yes
Cook
Yes
Goodell
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Skartados
Yes
Corwin
Yes
Gottfried
Yes
Magee
Yes
Perry
Yes
Skoufis
Yes
Crespo
Yes
Graf
Yes
Magnarelli
Yes
Pichardo
Yes
Solages
Yes
Crouch
Yes
Gunther
Yes
Malliotakis
Yes
Pretlow
Yes
Stec
‡ Indicates voting via videoconference
S06477 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 6477--B Cal. No. 104 IN SENATE January 28, 2014 ___________ Introduced by Sens. HANNON, BOYLE, BALL, CARLUCCI, ESPAILLAT, GRISANTI, HASSELL-THOMPSON, HOYLMAN, KENNEDY, KRUEGER, LANZA, MARCHIONE, MARTINS, MONTGOMERY, PARKER, RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading -- again amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the public health law, in relation to use of opioid antagonists The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 3309 of the public health law, as added by chapter 2 413 of the laws of 2005, is amended to read as follows: 3 § 3309. Opioid overdose prevention. 1. The commissioner is authorized 4 to establish standards for approval of any opioid overdose prevention 5 program, and opioid antagonist prescribing, dispensing, distribution, 6 possession and administration pursuant to this section which may 7 include, but not be limited to, standards for program directors, appro- 8 priate clinical oversight, training, record keeping and reporting. 9 2. Notwithstanding any inconsistent provisions of section sixty-five 10 hundred twelve of the education law or any other law, the purchase, 11 acquisition, possession or use of an opioid antagonist pursuant to this 12 section shall not constitute the unlawful practice of a profession or 13 other violation under title eight of the education law or this article. 14 3. (a) As used in this section: 15 (i) "Opioid antagonist" means a drug approved by the Food and Drug 16 Administration that, when administered, negates or neutralizes in whole 17 or in part the pharmacological effects of an opioid in the body. "Opioid 18 antagonist" shall be limited to naloxone and other medications approved 19 by the department for such purpose. 20 (ii) "Health care professional" means a person licensed, registered or 21 authorized pursuant to title eight of the education law to prescribe 22 prescription drugs. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD13628-05-4S. 6477--B 2 1 (iii) "Pharmacist" means a person licensed or authorized to practice 2 pharmacy pursuant to article one hundred thirty-seven of the education 3 law. 4 (iv) "Opioid antagonist recipient" or "recipient" means a person at 5 risk of experiencing an opioid-related overdose, or a family member, 6 friend or other person in a position to assist a person experiencing or 7 at risk of experiencing an opioid-related overdose, or an organization 8 registered as an opioid overdose prevention program pursuant to this 9 section. 10 (b)(i) A health care professional may prescribe by a patient-specific 11 or non-patient-specific prescription, dispense or distribute, directly 12 or indirectly, an opioid antagonist to an opioid antagonist recipient. 13 (ii) A pharmacist may dispense an opioid antagonist, through a 14 patient-specific or non-patient-specific prescription pursuant to this 15 paragraph, to an opioid antagonist recipient. 16 (iii) An opioid antagonist recipient may possess an opioid antagonist 17 obtained pursuant to this paragraph, may distribute such opioid antag- 18 onist to a recipient, and may administer such opioid antagonist to a 19 person the recipient reasonably believes is experiencing an opioid over- 20 dose. 21 (iv) The provisions of this paragraph shall not be deemed to require a 22 prescription for any opioid antagonist that does not otherwise require a 23 prescription; nor shall it be deemed to limit the authority of a health 24 care professional to prescribe, dispense or distribute, or of a pharma- 25 cist to dispense, an opioid antagonist under any other provision of law. 26 4. Use of an opioid antagonist pursuant to this section shall be 27 considered first aid or emergency treatment for the purpose of any stat- 28 ute relating to liability. 29 [4.] A recipient or opioid overdose prevention program under this 30 section, acting reasonably and in good faith in compliance with this 31 section, shall not be subject to criminal, civil or administrative 32 liability solely by reason of such action. 33 5. The commissioner shall publish findings on statewide opioid over- 34 dose data that reviews overdose death rates and other information to 35 ascertain changes in the cause and rates of fatal opioid overdoses. The 36 report may be part of existing state mortality reports issued by the 37 department, and shall be submitted annually [for three years and as38deemed necessary by the commissioner thereafter,] to the governor, the 39 temporary president of the senate [and], the speaker of the assembly, 40 and the chairs of the senate and assembly health committees. The report 41 shall include, at a minimum, the following information: 42 (a) information on opioid overdose deaths, including age, gender, 43 ethnicity, and geographic location; 44 (b) data on emergency room utilization for the treatment of opioid 45 overdose; 46 (c) data on utilization of pre-hospital services; 47 (d) [suggested improvements in data collection.] data on utilization 48 of opioid antagonists; and 49 (e) any other information necessary to ascertain the success of the 50 program and ways to further reduce overdoses. 51 § 2. This act shall take effect immediately.